Revvity Inc. (NYSE:RVTY) Stock Has Consensus Price Target of $116.57 According to Analysts

Revvity Inc. (NYSE:RVTY) has earned a consensus recommendation of “Hold” from the eighteen ratings firms that are covering the stock, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $116.57.

A number of equities research analysts have issued reports on RVTY shares. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Royal Bank Of Canada began coverage on Revvity in a research report on Tuesday, September 1st. They set a “sector perform” rating and a $135.00 target price on the stock. UBS Group started coverage on Revvity in a report on Wednesday, September 9th. They set a “neutral” rating and a $140.00 price target on the stock. Finally, TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th.

Revvity Stock Performance

Revvity stock opened at $151.46 on Friday. The company’s 50-day moving average price is $128.26 and its 200-day moving average price is $108.85. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The company has a market cap of $16.90 billion, a PE ratio of 72.13, a price-to-earnings-growth ratio of 2.76 and a beta of 1.06. Revvity has a twelve month low of $81.22 and a twelve month high of $158.28.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities research analysts forecast that Revvity will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

Insider Activity

In related news, insider Maxwell Krakowiak sold 1,631 shares of the company’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $144.53, for a total transaction of $235,728.43. Following the transaction, the insider directly owned 14,781 shares in the company, valued at approximately $2,136,297.93. This represents a 9.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares in the company, valued at $934,738.80. This trade represents a 52.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 9,130 shares of company stock valued at $1,290,745 in the last 90 days. Company insiders own 0.85% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of RVTY. Ascentis Independent Advisors bought a new stake in shares of Revvity during the 1st quarter worth approximately $29,000. SJS Investment Consulting Inc. boosted its holdings in Revvity by 5,210.0% during the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after acquiring an additional 521 shares during the period. Global Retirement Partners LLC bought a new position in Revvity in the 2nd quarter valued at $51,000. Summit Securities Group LLC grew its position in Revvity by 294.6% in the 1st quarter. Summit Securities Group LLC now owns 663 shares of the company’s stock valued at $58,000 after acquiring an additional 495 shares during the last quarter. Finally, Contravisory Investment Management Inc. purchased a new stake in Revvity in the first quarter worth $66,000. Institutional investors own 86.65% of the company’s stock.

About Revvity

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.